MYGN 8-K 2026-01-12

MYRIAD GENETICS INC (MYGN) 8-K dated 2026-01-12 — accession 0000899923-26-000003. This URL is the filing, not the MYGN hub.

MYRIAD GENETICS INC (MYGN) is a diagnostics & research company listed on NASDAQ.

MYRIAD GENETICS INC filed a 8-K on 2026-01-12. Accession 0000899923-26-000003.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.

Not investment advice. The MYGN SEC hub lists recent forms. The stock page is the research view.